AMA Journal of Ethics^®

Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment.

Dr Chloë G. K. Atkins joins Ethics Talk to discuss her article, coauthored with Dr Sunit Das: “What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions?”

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

Ari Ne’eman joins Ethics Talk to discuss his article, When Disability is Defined by Behavior, Outcome Measures Should Not promote “Passing”.

Clinicians can practice disability humility by developing social understandings of disability.

Defining typical appearance as a goal of health service provision is harmful and unnecessary for traits that are stigmatized but neither harmful nor distressing.

The BRAINEATERS series consider an artist’s experiences of diagnosis, routine surveillance, and ongoing reorientation to her future.

Connections between racism and dehumanization have immediate, lethal, deleterious, longer-term consequences. Lessons from Nazi eugenics and human experimentation still apply.

Clinicians can practice disability humility by developing social understandings of disability. This can help clinicians improve communication and express respect for patients’ authority about their experiences.